Colorectal cancer screening: prospects for molecular stool analysis.
Colorectal cancer is common. As many patients present with advanced disease, an effective screening test would have substantial clinical benefits. Recent progress in understanding the biology of colorectal cancer (and of cancer cells in general) has led to possible new approaches to screening. In particular, there are prospects of developing tests based on analysis of stool, which promise improved accuracy, safety, affordability and patient compliance.
Davies
R Justin
RJ
Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, Hills Road, Cambridge, CB2 2XZ, UK.
Miller
Richard
R
Coleman
Nicholas
N
D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000235:genetics* / Q000473:pathology; D004273:DNA, Neoplasm; D005243:Feces; D005819:Genetic Markers; D006801:Humans; D008403:Mass Screening / Q000639:trends*; D009360:Neoplastic Cells, Circulating; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D004273:DNA, Neoplasm; D005819:Genetic Markers